ES2788300T3 - Regeneración hepática - Google Patents

Regeneración hepática Download PDF

Info

Publication number
ES2788300T3
ES2788300T3 ES11839627T ES11839627T ES2788300T3 ES 2788300 T3 ES2788300 T3 ES 2788300T3 ES 11839627 T ES11839627 T ES 11839627T ES 11839627 T ES11839627 T ES 11839627T ES 2788300 T3 ES2788300 T3 ES 2788300T3
Authority
ES
Spain
Prior art keywords
regeneration
liver
cells
mice
vegfr2
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES11839627T
Other languages
English (en)
Spanish (es)
Inventor
Shahin Rafii
Bi-Sen Ding
Sina Y Rabbany
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cornell University
Original Assignee
Cornell University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cornell University filed Critical Cornell University
Application granted granted Critical
Publication of ES2788300T3 publication Critical patent/ES2788300T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1858—Platelet-derived growth factor [PDGF]
    • A61K38/1866—Vascular endothelial growth factor [VEGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/44—Vessels; Vascular smooth muscle cells; Endothelial cells; Endothelial progenitor cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1825—Fibroblast growth factor [FGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/067—Hepatocytes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/28—Vascular endothelial cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • Vascular Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Developmental Biology & Embryology (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
ES11839627T 2010-11-09 2011-11-09 Regeneración hepática Active ES2788300T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US41173210P 2010-11-09 2010-11-09
US201161545851P 2011-10-11 2011-10-11
PCT/US2011/059960 WO2012064834A2 (en) 2010-11-09 2011-11-09 Methods for organ regeneration

Publications (1)

Publication Number Publication Date
ES2788300T3 true ES2788300T3 (es) 2020-10-21

Family

ID=46051533

Family Applications (1)

Application Number Title Priority Date Filing Date
ES11839627T Active ES2788300T3 (es) 2010-11-09 2011-11-09 Regeneración hepática

Country Status (9)

Country Link
US (2) US10946066B2 (cg-RX-API-DMAC7.html)
EP (2) EP3721897B1 (cg-RX-API-DMAC7.html)
JP (3) JP6189216B2 (cg-RX-API-DMAC7.html)
AU (3) AU2011326562B2 (cg-RX-API-DMAC7.html)
CA (1) CA2816593C (cg-RX-API-DMAC7.html)
DK (1) DK2637683T3 (cg-RX-API-DMAC7.html)
ES (1) ES2788300T3 (cg-RX-API-DMAC7.html)
SG (2) SG190206A1 (cg-RX-API-DMAC7.html)
WO (1) WO2012064834A2 (cg-RX-API-DMAC7.html)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2816593C (en) * 2010-11-09 2021-05-25 Shahin Rafii Methods for organ regeneration
AU2013267422B2 (en) 2012-05-30 2018-07-26 Cornell University Generation of functional and durable endothelial cells from human amniotic fluid-derived cells
JP6076076B2 (ja) * 2012-12-21 2017-02-08 日東電工株式会社 組織再生促進剤
CN106574243B (zh) 2014-06-27 2021-02-23 安吉克莱茵生物科学有限公司 表达腺病毒e4orf1的神经细胞及其制备方法和应用
WO2016069897A1 (en) * 2014-10-30 2016-05-06 Massachusetts Institute Of Technology Materials and methods for rescue of ischemic tissue and regeneration of tissue integrity during restriction, engraftment and transplantation
CA2971439A1 (en) * 2014-12-19 2016-06-23 Angiocrine Bioscience, Inc. Biocompatible implants comprising engineered endothelial cells
HK1258452A1 (zh) 2015-07-20 2019-11-15 Angiocrine Bioscience, Inc. 表达ets转录因子的工程化的内皮细胞
CN105213230A (zh) * 2015-09-22 2016-01-06 薇碧生物科技（上海）有限公司 一种基于不可见光和酶抑制物来促进胶原蛋白再生的方法
AU2017326174B2 (en) 2016-09-13 2024-02-22 Angiocrine Bioscience, Inc. Blood-brain barrier comprising engineered endothelial cells
EP3576756A4 (en) 2017-02-03 2020-12-16 Cornell University STABLE THREE-DIMENSIONAL BLOOD VESSELS AND THEIR FORMATION PROCESSES
US20200155648A1 (en) * 2017-06-28 2020-05-21 Children's Medical Center Corporation Promoting lung growth
EP4380601A4 (en) * 2021-08-06 2025-06-25 Trujillo, Charles, Nathan SYSTEM AND METHOD FOR TREATING OR PREVENTING RESPIRATORY FAILURE WITH AEROSOLIZED COLLAGENASE
US12385002B1 (en) * 2022-01-21 2025-08-12 Sahar M. H. Jaffal Automated primary cells' triturator

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06284883A (ja) * 1992-07-10 1994-10-11 Sanyo Chem Ind Ltd 肝細胞培養方法
US9585916B2 (en) * 1999-03-26 2017-03-07 Northern Therapeutics Inc. Cell based therapy for the pulmonary system
WO2002062971A1 (en) 2001-02-07 2002-08-15 Korea Atomic Energy Research Institute Method of isolating epithelial cells, method of preconditioning cells, and methods of preparing bioartificial skin and dermis with the epithelial cells or the preconditioned cells
IL165392A0 (en) * 2002-06-05 2006-01-15 Genentech Inc Compositions and methods for liver growth and liver protection
EP1815244A4 (en) 2004-11-11 2009-07-22 Agency Science Tech & Res CELL CULTURE DEVICE
JP4916159B2 (ja) 2005-11-09 2012-04-11 国立大学法人東北大学 生体管路ステント
US20080176206A1 (en) 2007-01-18 2008-07-24 Toshiharu Shinoka Cardiovascular tissue culture substrate
WO2008089448A2 (en) * 2007-01-19 2008-07-24 Cornell Presearch Foundation, Inc. Methods and compositions for promoting survival & proliferation of endothelial cells & stimulating angiogenesis
CN101275121B (zh) * 2007-03-26 2011-05-11 芦银雪 体外培养扩增的人肝脏祖先细胞及其制备方法
MX2013003522A (es) 2010-10-01 2013-05-22 Cipla Ltd Composicion farmaceutica.
CA2816593C (en) * 2010-11-09 2021-05-25 Shahin Rafii Methods for organ regeneration

Also Published As

Publication number Publication date
WO2012064834A3 (en) 2012-07-19
CA2816593A1 (en) 2012-05-18
EP2637683A2 (en) 2013-09-18
EP3721897B1 (en) 2025-10-08
US20210236598A1 (en) 2021-08-05
JP6189216B2 (ja) 2017-08-30
WO2012064834A2 (en) 2012-05-18
JP2013543760A (ja) 2013-12-09
SG10201509096SA (en) 2015-12-30
SG190206A1 (en) 2013-06-28
EP2637683B1 (en) 2020-03-04
US20130224161A1 (en) 2013-08-29
JP2020023565A (ja) 2020-02-13
US10946066B2 (en) 2021-03-16
CA2816593C (en) 2021-05-25
DK2637683T3 (da) 2020-05-25
AU2011326562B2 (en) 2017-02-23
EP3721897A1 (en) 2020-10-14
EP2637683A4 (en) 2015-10-28
AU2018282248A1 (en) 2019-01-17
AU2017202119A1 (en) 2017-04-20
AU2017202119B2 (en) 2019-01-03
JP2018012704A (ja) 2018-01-25
AU2011326562A1 (en) 2013-06-06

Similar Documents

Publication Publication Date Title
ES2788300T3 (es) Regeneración hepática
CN102388127B (zh) 肺的组织改造
ES2625041T3 (es) Tratamiento de degenaration de disco intervertebral usando células derivadas de tejido del cordón umbilical e hidrogel
ES2621610T3 (es) Tratamiento de la degeneración de discos intervertebrales utilizando células derivadas de tejido cordón umbilical humano
Makarevich et al. Enhanced angiogenesis in ischemic skeletal muscle after transplantation of cell sheets from baculovirus-transduced adipose-derived stromal cells expressing VEGF165
US20120093885A1 (en) Therapeutic vesicles
JP2010506563A (ja) 組織修復および再生における腎臓由来細胞およびその使用方法
Mokbel et al. Homing and efficacy of intra-articular injection of autologous mesenchymal stem cells in experimental chondral defects in dogs
CN107249607A (zh) 包括工程化内皮细胞的生物相容性植入物
Huang et al. Gene manipulated peritoneal cell patch repairs infarcted myocardium
WO2019098264A1 (ja) Ｃｄ３１陽性ｃｄ４５陰性ｃｄ２００陽性の哺乳動物細胞からなる細胞集団、およびその利用
Dorrello et al. Bioengineering of pulmonary epithelium with preservation of the vascular niche
WO2009052211A1 (en) Compositions and methods for enhancing lymphangiogenesis
ES2623142T3 (es) Un método para amplificar las células madre cardíacas in vitro e in vivo
Hong et al. Enhanced intramyocardial vascular cell delivery promotes post-myocardial infarction healing by polarizing pro-regenerative neutrophils
Tedeschi Mesoangioblast promote regeneration of a stable and organised vasculature in a decellularised intestinal graft
Alderfer Engineering Tunable Synthetic Biomaterials for Mechanistic and Therapeutic Lymphatic Vasculature Applications
JP2017514523A (ja) 細胞培養方法
US20130287745A1 (en) Compositions and methods to stimulate vascular structure formation
Fazel Cardiac repair and not regeneration after myocardial infarction: the role and therapeutic utility of the c-kit
Liu IGF-1 transfection enhances cardiac smooth muscle cell engraftment